BioSpace News Archive

DBV Technologies Announces Results of its 2024 Combined General Meeting

DBV Technologies, a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, held its Combined General Meeting.

May 16, 2024
·
2 min read
Biotech Bay

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 16, 2024

Geron Corporation, a late-stage clinical biopharmaceutical company, reported that it has granted non-statutory stock options to purchase an aggregate of 2,910,780 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.

May 16, 2024
·
2 min read
Drug Development

Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial

Tourmaline Bio, Inc. today announced that the first patient has been dosed in its Phase 2 TRANQUILITY trial, marking the initiation of its clinical development program for TOUR006.

May 16, 2024
·
6 min read
First Wave BioPharma Changes Name to Entero Therapeutics

Entero Therapeutics, Inc. today unveiled its new corporate name and website.

May 16, 2024
·
4 min read
Deals

Monte Rosa Therapeutics Announces Pricing of $100 Million Underwritten Public Offering

Monte Rosa Therapeutics, Inc. today announced the pricing of an underwritten public offering of 10,638,476 shares of its common stock at a public offering price of $4.70 per share.

May 16, 2024
·
5 min read
Lone Star Bio

FX Shoulder Solutions, Inc. Receives FDA 510k Clearance for Full-Wedge Augmented Glenoid Baseplates

FX received 510k clearance for its full-wedge augmented glenoid baseplates.

May 16, 2024
·
1 min read
Deals

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders - May 16, 2024

Oncolytics Biotech ® Inc. today announced the voting results from its Annual General Meeting (AGM) of Shareholders held on Wednesday, May 15, 2024.

May 16, 2024
·
2 min read
Genetown

Liberate Bio Announces Presentation to Update on Advancements on their RAPTOR LNP Platform

Liberate Bio, Inc. announced an oral presentation demonstrating the success of their RAPTOR™ screening platform and its first generation of extrahepatic lipid nanoparticles at the Oligonucleotide and Peptide Therapeutics 2024 (TIDES) being held May 14-17, 2024, in Boston, Massachusetts.

May 16, 2024
·
2 min read
Business

Nucleai Appoints Vikas Ahuja as Vice President of Strategic Partnerships to Enable Diagnostic Deployment and Commercialization at Scale

Nucleai announced today the expansion of its executive leadership team with the appointment of Vikas Ahuja as Vice President of Strategic Partnerships.

May 16, 2024
·
3 min read
Business

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

Nutriband Inc., a developer of transdermal pharmaceutical solutions, announced the appointment of Sergei Glinka to its board of directors.

May 16, 2024
·
4 min read